DFDA

Surgical Repair of Congenital Heart Defects

Treatment for Down Syndrome

Effectiveness
90%
Safety Score
60%
Clinical Trials
1
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Time to Effect
immediate (post-recovery)
Treatment Duration
one-time surgery, followed by lifelong monitoring
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$2,000
Total Annual:$3,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
10
Outcome-Based Costs
Cost per Responder
$3,333.33
Cost per Remission
$3,529.41
Surgical Repair of Congenital Heart Defects Outcomes

for Down Syndrome

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Infection
+8%
Arrhythmias
+10%
Bleeding
+5%
Post-operative pain
+30%

Sources:

researchgate.net
nih.gov
johnshopkins.edu

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Surgical Repair of Congenital Heart Defects in Down Syndrome

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

NCT05312177COMPLETED
View Study
273 participants
OBSERVATIONAL
Wilmington, United States +13 more
Started: May 1, 2022